Treatment with infliximab in a patient with ankylosing spondylitis and Crohn's disease
Rednic, S.; Marinescu, C.; Chira, R.; Rogojan, L.; Rednic, N.
Journal of Gastrointestinal and Liver Diseases Jgld 15(4): 379-382
2006
ISSN/ISBN: 1842-1121
PMID: 17205151
Accession: 050851299
The association of Crohn's disease and ankylosing spondylitis is described in up to 30% of cases. Treatment of both conditions is not an easy task. We present the case of a 53 year old woman, diagnosed with colonic Crohn's disease and ankylosing spondilitis, treated initially with increasing doses of sulphasalazine and moderate dose of corticosteroids, with the persistence of severe gastrointestinal and articular symptoms. She underwent therapy with tumor necrosis factor alpha (TNFalpha) inhibitor infliximab, with a spectacular improvement of symptoms, signs and quality of life.
PDF emailed within 1 workday: $29.90
Related References
Chun-De, Bao 2008: New weapon in arsenal infliximab in treatment of rheumatoid arthritis, ankylosing spondylitis, and Crohn s disease Zhongguo Xinyao yu Linchuang Zazhi 27(3): 233-236Famenini, S.; Wu, J.J. 2013: Infliximab-induced psoriasis in treatment of Crohn's disease-associated ankylosing spondylitis: case report and review of 142 cases Journal of Drugs in Dermatology: Jdd 12(8): 939-943
Rahman, P.; Choquette, D.; Khraishi, M.; Bensen, W.; Shaikh, S.; Sholter, D.; Sheriff, M.; Rampakakis, E.; Sampalis, J.S.; Nantel, F.; Otawa, S.; Lehman, A.; Shawi, M. 2014: SAT0363Validation of the Ankylosing Spondylitis Disease Activity SCORE (ASDAS) and Effectiveness of Infliximab in the Treatment of Ankylosing Spondylitis over 4 Years Annals of the Rheumatic Diseases 73(Suppl 2): 725.1-725
Rebelo, A.; Leite, Sílvía.; Cotter, Jé. 2010: Association of ankylosing spondylitis and Crohn's disease successfully treated with infliximab Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 24 Suppl. 1: 37-39
Steenholdt, C.; Brynskov, J.; Thomsen, O..; Munck, L.K.; Fallingborg, J.; Christensen, L.A.; Pedersen, G.; Kjeldsen, J.; Jacobsen, B.A.; Oxholm, A.S.; Kjellberg, J.; Bendtzen, K.; Ainsworth, M.A. 2013: Treatment of Secondary Infliximab Failure in Crohn's Disease Based on Serum Levels of Infliximab and Antibodies Against Infliximab: The Danish Study of Optimizing Infliximab Therapy in Crohn's Disease (Do It Crohn) Randomized Clinical Trial Gastroenterology 144(5): S-22
Kwon, S.-R.; Jung, K.-H.; Lim, M.-J.; Son, M.-J.; Choi, B.H.; Park, S.-G.; Park, W. 2017: The effect of anti-TNF treatment on osteoblastogenesis in ankylosing spondylitis: the number of circulating osteoblast-lineage cells in peripheral blood decreased after infliximab therapy in patients with ankylosing spondylitis Clinical and Experimental Rheumatology 35(5): 837-843
Cooper, J.; Flückiger, B.; Traichl, B.; Diener, P.-A.é; Otto, P.; von Kempis, J. 2009: Abdominal pain in a patient with ankylosing spondylitis under treatment with infliximab Journal of Clinical Rheumatology: Practical Reports on Rheumatic and Musculoskeletal Diseases 15(5): 244-246
Nazarinia, M.A.; Ghaffarpasand, F.; Seraj, S.R.; Heiran, H.R.; Khojasteh, H.N. 2010: Imatinib treatment of ankylosing spondylitis in a patient resistant to NSAIDs and infliximab Journal of Clinical Rheumatology: Practical Reports on Rheumatic and Musculoskeletal Diseases 16(3): 140-142
Matsuda, J.; Kaburaki, T.; Kobayashi, S.; Numaga, J. 2013: Treatment of recurrent anterior uveitis with infliximab in patient with ankylosing spondylitis Japanese Journal of Ophthalmology 57(1): 104-107
Heldmann, F.; Brandt, J.; van der Horst-Bruinsma, I.E.; Landewe, R.; Sieper, J.; Burmester, G.R.; van den Bosch, F.; de Vlam, K.; Geusens, P.; Gaston, H.; Schewe, S.; Appelboom, T.; Emery, P.; Dougados, M.; Leirisalo-Repo, M.; Breban, M.; Listing, J.; Braun, J. 2011: The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab Clinical and Experimental Rheumatology 29(4): 672-680
Aybay, C.; Ozel, S.; Aybay, C. 2006: Demonstration of specific antibodies against infliximab induced during treatment of a patient with ankylosing spondylitis Rheumatology International 26(5): 473-480
Vilela Lopes, R.; Barros Ohashi, C.; Helena Cavaleiro, L.; de Britto Pereira Cruz, R.; da Veiga, R.R.G.; Fernando Ribeiro Miranda, M.ár.; Toshimitsu Yoshikawa, G. 2009: Development of leprosy in a patient with ankylosing spondylitis during the infliximab treatment: reactivation of a latent infection? Clinical Rheumatology 28(5): 615-617
Bidad, K.; Fallahi, S.; Mahmoudi, M.; Jamshidi, A.; Farhadi, E.; Meysamie, A.; Nicknam, M.H. 2012: Evaluation of the Iranian versions of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Patient Acceptable Symptom State (PASS) in patients with ankylosing spondylitis Rheumatology International 32(11): 3613-3618
Brulhart, L.; Nissen, M.J.; Chevallier, P.; Gabay, C. 2010: Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists Joint Bone Spine 77(6): 625-626
El Miedany, Y.; Youssef, S.; Mehanna, A.; Shebrya, N.; Abu Gamra, S.; El Gaafary, M. 2008: Defining disease status in ankylosing spondylitis: validation and cross-cultural adaptation of the Arabic Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and the Bath Ankylosing Spondylitis Global score (BASG) Clinical Rheumatology 27(5): 605-612
Akdoğan, M.F.; Gücün, M.; Denizli, N.ım.; Güney, M.; Akdag, I.; Ozcan, T.B.; Duranay, M. 2011: Complete reversal of nephrotic syndrome secondary to amyloidosis with use of infliximab in a patient with inflammatory bowel disease and ankylosing spondylitis Renal Failure 33(5): 531-533
Visvanathan, S.; Wagner, C.; Marini, J.C.; Baker, D.; Gathany, T.; Han, J.; van der Heijde, D.; Braun, J. 2008: Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab Annals of the Rheumatic Diseases 67(4): 511-517
Appel, H.; Hermann, K.-G.A.; Althoff, C.E.; Rudwaleit, M.; Sieper, J. 2007: Whole-body magnetic resonance imaging evaluation of widespread inflammatory lesions in a patient with ankylosing spondylitis before and after 1 year of treatment with infliximab Journal of Rheumatology 34(12): 2497-2498
Kim, H.Y.; Kim, T.W. 2017: Crohn's disease with ankylosing spondylitis in an adolescent patient who had undergone long ileo-colonic anastomosis for Hirschsprung's disease as an infant Intestinal Research 15(1): 133-137
Jethwa, H.; Mann, S. 2013: Crohn's disease unmasked following etanercept treatment for ankylosing spondylitis BMJ Case Reports